HSE PharmaVax Review
The HSE Pharmacy eVaccinations Working Group is seeking feedback from IPU members to assist with a review of HSE PharmaVax and to help inform the technical roadmap for the system. This is an opportunity to share your experiences and challenges with using the system and to influence improvements. The more feedback we get, the more we can influence developments. If you can participate, please email your feedback to pharmacists@ipu.ie before 12 February.
Removal of COVID-19 vaccine types
The HSE has notified vaccinators that Spikevax bivalent Original/Omicron BA.4-5 (COVID-19 Vaccine) will be removed from HSE PharmaVax on 12 March 2024 as this product is no longer in use. The letter can be viewed on the IPU COVID-19 Hub in Section 7 HSE Circulars.